Lysosomal integral membrane protein-2: A new player in lysosome-related pathology

详细信息    查看全文

• 作者：Ashley Gonzalez ; Mark Valeiras ; Ellen Sidransky ; Nahid Tayebi
• 关键词：Lysosomal integral membrane protein-2 ; Lysosomal membrane protein ; Gaucher disease ; Action myoclonus renal failure ; Glucocerebrosidase ; Transporter
• 刊名：Molecular Genetics and Metabolism
• 出版年：February, 2014
• 年：2014
• 卷：111
• 期：2
• 页码：84-91
• 全文大小：492 K

文摘

Lysosomes require the presence of many specialized proteins to facilitate their roles in cellular maintenance. One such protein that has proven to be an important player in the lysosomal field is lysosomal integral membrane protein-2 (LIMP-2), encoded by the gene SCARB2. LIMP-2 is required for the normal biogenesis and maintenance of lysosomes and endosomes and has been identified as the specific receptor for glucocerebrosidase, the enzyme deficient in Gaucher disease. Research into LIMP-2 and the SCARB2 gene indicate that it may be a factor contributing to the clinical heterogeneity seen among patients with Gaucher disease. Mutations in SCARB2 have also been identified as the cause of action myoclonus renal failure (AMRF), and in some cases progressive myoclonic epilepsy. A total of 14 disease-causing SCARB2 mutations have been identified to date. The role of LIMP-2 in human pathology has expanded with its identification as a component of the intercalated disk in cardiac muscle and as a receptor for specific enteroviruses, two unanticipated findings that reaffirm the myriad roles of lysosomal proteins. Studies into the full impact of LIMP-2 deficiency and the LIMP2/glucocerebrosidase molecular pathway will lead to a better understanding of disease pathogenesis in Gaucher disease and AMRF, and to new insights into lysosomal processing, trafficking and function.